Medical Design Briefs Podcast SAE Media Group

In this season, we are taking an in-depth look at medical-grade wearables. Nick Annetta, senior electrical engineer at Priority Designs talks to us about advances such as miniaturization that have led to the evolution of wearable devices. We will explore how these innovations are reshaping the future of healthcare, making treatments more precise, portable, and patient-friendly than ever before.

This episode addresses the integration of artificial
intelligence with biosensors, exploring how AI algorithms analyze and interpret the data collected, leading to more accurate diagnostics, predictive insights, and personalized health recommendations.

In this episode, we explore advancements in wearable injector technology, examining how these devices are transforming the administration of medications, improving patient adherence, and enhancing the overall effectiveness of treatment plans. Our guest is Matt Huddleston, chief technology officer and executive vice president of Enable
Injections, who talks about the enFuse infusion platform.

DNA or aptamer-based biosensors offer a highly sensitive, specific, and versatile approach for detecting a wide range of target molecules, with applications ranging from medical diagnostics to health monitoring. On this episode of Medical Design Briefs’ Podcast, Rob Batchelor, head of biosensors at Nutomics explores the latest developments in aptamer-based biosensors, discussing how they enable real-time monitoring of vital signs, biomarkers, and health parameters, providing valuable data for personalized healthcare.

Surgery- and drug-free at-home wearable neuromodulation
represents a huge advancement for a variety of clinical conditions, including overactive bladder syndrome, which affects more than 46 million people in the U.S. On this episode of Medical Design Briefs’ Podcast, Jill Schiaparelli, CEO of Avation Medical discusses the first FDA-cleared, non-invasive, closed-loop wearable neuromodulation technology for at-home bladder treatment. From understanding the technology behind it to its real-world impact on patients and clinicians, this podcast uncovers the potential of wearable neuromodulation in revolutionizing the treatment of OAB.

 

On this episode of Medical Design Briefs’ Podcast, our guest Ashkan Vaziri, founder and CEO of Biosensics, examines how medtech and pharmaceutical companies can leverage the power of wearables to not only see a great increase in patient engagement but also to gather robust data for the clinical trial.